OREANDA-NEWS. HMS Holdings Corp.  (NASDAQ:HMSY) today announced financial results for the second quarter of 2016. Net income for the quarter ended June 30, 2016 was $8.6 million or $0.10 per diluted share, compared to net income of $4.6 million or $0.05 per diluted share in the first quarter of 2016 and $5.4 million or $0.06 per diluted share in the prior year second quarter. Adjusted EPS in the quarter was $0.18 per diluted share compared to adjusted EPS of $0.13 per diluted share in the prior year second quarter. Total revenue in the quarter was $123.6 million, compared to $119.8 million in the first quarter of 2016 and $116.9 million in the prior year second quarter.

“With commercial health plan revenue up 20% in the first half of this year, compared to the comparable period in 2015, we are on course to achieve our full-year growth target of 18-20%. The addition this quarter of approximately 15 million new commercial lives and the sale of incremental products to current health plan customers covering approximately 3.1 million of their members resulted in a record quarter for our sales team. Of particular significance,  the new lives are a combination of commercial at-risk and administrative services only (ASO) lives and virtually all sales in the quarter were for payment integrity products," said Bill Lucia, Chairman and CEO. "Up to this point nearly all of our work for health plan customers has been for their Medicaid managed care and Medicare Advantage populations, with a focus primarily on our coordination of benefits product line. As many of the larger national and regional plans address ongoing cost challenges, we expect there will be a growing opportunity to sell our payment integrity cost containment solutions for their commercial at-risk and ASO populations - which presents a significant growth opportunity for HMS."

Total revenue in the second quarter of 2016 of $123.6 million was approximately 5.7% higher than the prior year second quarter. Commercial health plan revenue in the quarter was $55.2 million, a 12.0% increase compared to $49.3 million in the prior year second quarter and a $0.8 million decline from the first quarter of 2016. State government revenue in the quarter was $57.6 million, compared to $57.2 million in the prior year second quarter, and an increase of $6.9 million compared to the first quarter of 2016.

Non-Medicare RAC Federal and other revenue was $6.7 million in the second quarter of 2016, a $0.2 million increase compared to the prior year second quarter and an increase of $1.9 million from the first quarter of 2016. Medicare RAC revenue in quarter was $4.1 million, compared to $3.9 million in the prior year second quarter and $8.3 million in the first quarter of 2016.

Coordination of Benefits (COB) revenue, which continues to be our largest product line across both the state government and commercial health plan sectors, was $89.7 million in the second quarter of 2016 compared to $83.0 million in the prior year second quarter and $82.9 million in the first quarter of 2016. COB revenue accounted for 73% of total revenue in the quarter, compared to 71% in the prior year second quarter and 69% in the first quarter of 2016. Payment integrity revenue (excluding Medicare RAC) was $29.8 million in the quarter, a $0.2 million or 0.7% decline from the second quarter of last year and a $1.2 million or 4.2% increase from the first quarter of 2016.

"Cash flow from operations of $45.1 million was particularly strong in the second quarter, as cash collections accelerated and accounts receivable declined. Quarter end cash on the balance sheet at June 30, 2016 increased to nearly $188 million and we are on track to reach our full year operating cash flow target in the $80 -100 million range," said Jeff Sherman, Chief Financial Officer. "As we have indicated previously, the primary capital allocation focus for our increasingly strong balance sheet is acquisitions to complement our core business; expand our data analytics capabilities to assist customers with member health management and/or member engagement; and add to our capacity to detect fraud, waste and abuse."

Webcast and Conference Call Information

HMS will report its second quarter 2016 financial and operating results via webcast at 7:30 AM CT / 8:30 AM ET on Friday, August 5, 2016. The webcast may also include discussion of HMS developments, and forward-looking and other material information about business and financial matters.  The webcast can be accessed via phone at (877) 303–7208 or (224) 357–2389 for international participants, or at http://investor.hms.com/events.cfm on the HMS Investor Relations website. The webcast will also be archived and available for replay beginning at approximately 11:00 AM CT / 12:00 PM ET on August 5, 2016 at http://investor.hms.com/events.cfm. This press release and the financial statements contained herein are also available at http://investor.hms.com/releases.cfm.

The HMS Quarterly Report on Form 10-Q for the period ended June 30, 2016 is expected to be filed and available on the HMS website at http://investor.hms.com/financials.cfm and at www.sec.gov on August 9, 2016 and will contain additional information about our results of operations for the fiscal year to date.

About HMS

HMS Holdings Corp., through its subsidiaries, provides coordination of benefits and payment integrity services for payers. The Company serves state Medicaid programs; health plans, including Medicaid managed care, Medicare Advantage and group and individual health lines of business; federal government health agencies, including the Centers for Medicare & Medicaid Services and the Veterans Health Administration; government and private employers; and other healthcare payers and sponsors, including child support agencies. As a result of the Company’s services, our customers recover billions of dollars annually and save billions more through the prevention of improper payments.

Non-GAAP Financial Measures

The Company reports and discusses its operating results using financial measures consistent with accounting principles generally accepted in the United States ("GAAP"). From time to time, in press releases, financial presentations, earnings conference calls or otherwise, the Company may disclose certain non-GAAP financial measures. The non-GAAP financial measures presented in this press release should not be viewed as alternatives or substitutes for the Company's reported GAAP results. A reconciliation to the most directly comparable GAAP financial measure is set forth in the tables that accompany this release.

The Company believes that the non-GAAP financial measures presented in this press release provide useful information to the Company's management, investors, and other interested parties about the Company's operating performance because they allow them to understand and compare the Company's operating results during the current periods to the prior year periods in a more consistent manner. The non-GAAP measures presented in this press release may not be comparable to similarly titled measures used by other companies. These non-GAAP financial measures are used in addition to and in conjunction with results presented in accordance with GAAP and reflect an additional way of viewing aspects of the Company's operations that, when viewed with GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provides a more complete understanding of the results of operations and trends affecting the Company's business. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to financial measures calculated in accordance with GAAP.

Safe Harbor Statement  

This press release contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such statements give our projections or forecasts of future events and are based on our current expectations and assumptions regarding our business, the economy and other future conditions; they do not relate strictly to historical or current facts. Forward?looking statements can be identified by words such as “aims,” “anticipates,” “believes,” “estimates,” “expects,” “forecasts,” “intends,” “likely,” “may,” “plans,” “projects,” “seeks,” “targets,” “will,” “would,” “could,” “should,” and similar expressions and references to guidance, although some forward-looking statements may be expressed differently. In particular, these include statements relating to future actions, business plans, objectives and prospects, future operating or financial performance. Factors or events that could cause actual results to differ may emerge from time to time and it is not possible for us to predict all of them. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected. We caution you therefore against relying on any of these forward-looking statements. 

Factors that could cause or contribute to such differences, include, but are not limited to:  changes in the U.S. healthcare environment or healthcare financing system; negative or reduced growth rate of spending on Medicaid/Medicare; our ability to retain customers or the loss of one or more major customers; the unexpected reduction in scope or termination of a significant contract; customer dissatisfaction or our non-compliance with contractual provisions or regulatory requirements; our failure to meet performance standards triggering significant costs or liabilities under our contracts; emergence of new competitors or competitors’ introduction of new or superior products or services; intellectual property rights, confidential and proprietary information; the cancellation or delay of procurements or contract implementation due to protests or challenges to government awards; regulatory, budgetary or political actions that affect procurement practices; our ability to continue to secure contracts or favorable contract terms through the competitive bidding process; our ability to execute our business plans or growth strategy; variations in our results of operations; development and implementation of new product solutions or new process improvements; the risk that guidance may not be achieved; our ability to maintain effective information and technology systems and networks, and to protect them from damage, interruption or breach, including cyber-security breaches and other disruptions; our failure to comply with applicable laws and regulations governing the conduct of certain electronic health transactions and the confidentiality of individually identifiable health information or to protect such information from theft and misuse; the nature of investment and acquisition opportunities we are pursuing, and the successful execution or integration of such investments and acquisitions; the failure to realize the full value of goodwill or intangible assets from acquisitions; negative results of government or customer reviews, audits or investigations; state or federal limitations related to the outsourcing of certain government programs or functions; our reliance on subcontractors, vendors or other third party providers and sources to perform services; pending or threatened litigation; unfavorable outcomes in legal proceedings; restrictions on bidding or performing certain work due to perceived conflicts of interests; our ability to attract and retain qualified employees and key personnel and to manage leadership transitions effectively; our cash flows from operations, available cash and ability to generate sufficient cash to cover our interest and principal payments under our credit facility or to borrow or use credit; unanticipated changes in our effective tax rates; unanticipated increases in the number or amount of claims for which we are self-insured; the market price of our common stock and lack of dividend payments; risks related to internal control over financial reporting; anti-takeover provisions in our corporate governance documents; and other factors, risks and uncertainties described in our most recent Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission. Any forward-looking statements are made as of the date of this press release. Except as may be required by law, we disclaim any obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise.

 

HMS HOLDINGS CORP. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share amounts)
(unaudited)
 
                         
          Three Months Ended
June 30,
  Six Months Ended
June 30,
 
             
            2016       2015       2016       2015    
  Revenue       $ 123,550     $ 116,934     $ 243,313     $ 227,258    
  Cost of services:                    
  Compensation       47,343       43,883       93,744       87,950    
  Data processing       9,104       10,438       18,728       20,483    
  Occupancy       3,631       3,806       7,258       7,813    
  Direct project expenses     11,473       13,572       25,955       24,050    
  Other operating expenses     6,407       7,153       12,184       13,891    
  Amortization of acquisition related software and intangible assets   7,013       7,047       14,026       14,094    
  Total cost of services     84,971       85,899       171,895       168,281    
  Selling, general and administrative expenses   22,227       19,283       45,157       39,244    
  Total operating expenses     107,198       105,182       217,052       207,525    
  Operating income     16,352       11,752       26,261       19,733    
  Interest expense       (2,100 )     (1,940 )     (4,191 )     (3,894 )  
  Interest income       60       12       107       23    
  Income before income taxes   14,312       9,824       22,177       15,862    
  Income taxes       5,746       4,406       9,051       6,922    
  Net income     $ 8,566     $ 5,418     $ 13,126     $ 8,940    
                         
  Basic income per common share:                
  Net income per common share -- basic $ 0.10     $ 0.06     $ 0.16     $ 0.10    
  Diluted income per common share:                
  Net income per common share -- diluted $ 0.10     $ 0.06     $ 0.15     $ 0.10    
  Weighted average shares:                  
  Basic         84,073       88,523       84,104       88,385    
  Diluted         84,528       88,908       84,923       88,771    
                         
  Certain reclassifications were made to prior period amounts to conform to current period presentations.
                         
HMS HOLDINGS CORP. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts)
 
                     
              June 30,
2016
  December 31,
2015
 
  Assets           (unaudited)      
  Current assets:                
  Cash and cash equivalents       $ 187,884     $ 145,610    
  Accounts receivable, net of allowance for doubtful accounts of $3,649 and $4,849, and estimated allowance for appeals of $6,483 and $6,614, at June 30, 2016 and December 31, 2015, respectively   152,339       169,146    
  Prepaid expenses         11,389       11,261    
  Deferred tax assets             5,285       7,460    
  Other current assets         399       3,051    
  Total current assets         357,296       336,528    
  Property and equipment, net         87,907       96,551    
  Goodwill             361,468       361,468    
  Intangible assets, net         44,222       54,308    
  Deferred financing costs, net         3,831       4,873    
  Other assets           4,649       4,329    
  Total assets         $ 859,373     $ 858,057    
                     
  Liabilities and Shareholders' Equity            
  Current liabilities:                
  Accounts payable, accrued expenses and other liabilities $ 40,450     $ 51,661    
  Estimated liability for appeals       30,586       33,078    
  Income taxes payable         700       3,873    
  Total current liabilities         71,736       88,612    
  Long-term liabilities:                
  Revolving credit facility         197,796       197,796    
  Deferred tax liabilities         33,899       38,421    
  Deferred rent           5,798       6,006    
  Other liabilities           3,017       2,520    
  Total long-term liabilities         240,510       244,743    
  Total liabilities           312,246       333,355    
  Commitments and contingencies (Note 11)          
  Shareholders' equity:              
  Preferred stock -- $0.01 par value; 5,000,000 shares authorized; none issued   -       -    
  Common stock -- $0.01 par value; 175,000,000 shares authorized; 95,711,773 shares issued and 84,438,027 shares outstanding at June 30, 2016; 95,263,461 shares issued
and 83,989,715 shares outstanding at December 31, 2015
  957       952    
  Capital in excess of par value         339,584       330,290    
  Retained earnings           301,600       288,474    
  Treasury stock, at cost: 11,273,746  shares at June 30, 2016 and December 31, 2015   (95,014 )     (95,014 )  
  Total shareholders' equity         547,127       524,702    
  Total liabilities and shareholders' equity   $ 859,373     $ 858,057    
                     
Certain reclassifications were made to prior period amounts to conform to current period presentation.
                     
HMS HOLDINGS CORP. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
                     
              Six Months Ended
June 30,
 
               
                2016       2015    
  Operating activities:              
  Net income         $   13,126     $   8,940    
  Adjustments to reconcile net income to net cash provided by operating activities:        
  Depreciation and amortization of property and equipment     12,784         16,002    
  Amortization of intangible assets         10,086         10,154    
  Amortization of deferred financing costs       1,042         1,042    
  Stock-based compensation expense       8,645         7,068    
  Excess tax benefit from exercised stock options     (1,313 )       (1,456 )  
  Deferred income taxes           (3,135 )       (3,483 )  
  Loss on disposal of fixed assets         44         10    
  Changes in operating assets and liabilities:          
  Accounts receivable           16,807         (10,161 )  
  Prepaid expenses           (128 )       628    
  Prepaid income taxes           -          6,265    
  Other current assets           2,652         5    
  Other assets             (320 )       (660 )  
  Income taxes payable           (1,860 )       -     
  Accounts payable, accrued expenses and other liabilities               (10,190 )       (11,479 )  
  Estimated liability for appeals         (2,492 )       (2,785 )  
  Net cash provided by operating activities       45,748         20,090    
  Investing activities:              
  Purchases of land, property and equipment       (2,122 )       (5,022 )  
  Investment in capitalized software         (2,752 )       (1,340 )  
  Net cash used in investing activities       (4,874 )       (6,362 )  
  Financing activities:              
  Proceeds from exercise of stock options       1,196         3,412    
  Excess tax benefit from exercised stock options       1,313         1,456    
  Payments of tax withholdings on behalf of employees for net-share settlement for stock-based compensation     (1,067 )       (628 )  
  Payments on capital lease obligations         (42 )       (655 )  
  Net cash provided by financing activities       1,400         3,585    
  Net increase in cash and cash equivalents       42,274         17,313    
  Cash and Cash Equivalents              
  Cash and cash equivalents at beginning of year       145,610         133,116    
  Cash and cash equivalents at end of year   $  187,884     $  150,429    
                     
  Supplemental disclosure of cash flow information:        
  Cash paid for income taxes       $   13,450     $   8,226    
  Cash paid for interest       $   3,016     $   3,868    
                     
  Supplemental disclosure of non-cash activities:          
  Change in balance of accrued property and equipment purchases $   (690 )   $   154    
                     
Certain reclassifications were made to prior period amounts to conform to current period presentation.